ASX - Delayed Quote AUD

Sonic Healthcare Limited (SHL.AX)

Compare
27.44
-0.12
(-0.44%)
At close: December 27 at 4:10:49 PM GMT+11
Loading Chart for SHL.AX
DELL
  • Previous Close 27.56
  • Open 27.48
  • Bid 27.20 x --
  • Ask 27.49 x --
  • Day's Range 27.26 - 27.53
  • 52 Week Range 23.58 - 32.57
  • Volume 640,370
  • Avg. Volume 899,833
  • Market Cap (intraday) 13.182B
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) 25.64
  • EPS (TTM) 1.07
  • Earnings Date Feb 20, 2025
  • Forward Dividend & Yield 1.06 (3.90%)
  • Ex-Dividend Date Sep 4, 2024
  • 1y Target Est 28.87

Sonic Healthcare Limited offers medical diagnostic and administrative services to medical practitioners, hospitals, community health services, and patients in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

www.sonichealthcare.com

42,000

Full Time Employees

June 30

Fiscal Year Ends

Recent News: SHL.AX

View More

Performance Overview: SHL.AX

Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SHL.AX
11.21%
S&P/ASX 200 [XJO]
8.84%

1-Year Return

SHL.AX
10.49%
S&P/ASX 200 [XJO]
9.27%

3-Year Return

SHL.AX
34.45%
S&P/ASX 200 [XJO]
11.34%

5-Year Return

SHL.AX
8.60%
S&P/ASX 200 [XJO]
21.11%

Compare To: SHL.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SHL.AX

View More

Valuation Measures

As of 12/27/2024
  • Market Cap

    13.18B

  • Enterprise Value

    17.05B

  • Trailing P/E

    25.60

  • Forward P/E

    25.97

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.46

  • Price/Book (mrq)

    1.66

  • Enterprise Value/Revenue

    1.91

  • Enterprise Value/EBITDA

    10.28

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.70%

  • Return on Assets (ttm)

    3.88%

  • Return on Equity (ttm)

    6.80%

  • Revenue (ttm)

    8.97B

  • Net Income Avi to Common (ttm)

    511.09M

  • Diluted EPS (ttm)

    1.07

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    645M

  • Total Debt/Equity (mrq)

    55.92%

  • Levered Free Cash Flow (ttm)

    427.14M

Research Analysis: SHL.AX

View More

People Also Watch